Gender disparities in the National Institutes of Health funding for gastrointestinal oncology. Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively ...
Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group PURPOSE: To characterize the clinical and biologic features of ...
A 31-year-old man presented to his urologist with a left hemiscrotal mass. Following left radical orchiectomy, pathology demonstrated a mixed germ-cell neoplasm with angiolymphatic invasion. Although ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback